|
|
||||||||
Regular Article |
a Smithsonian Institution, National Zoological Park and Conservation and Research Center, Washington, District of Columbia 20008
b Department of Entomology, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910-7500
c Department of Physics, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana 46202
d Department of Radiology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205
e Smithsonian Institution, National Zoological Park, Department of Zoological Research and Molecular Genetics Laboratory, Washington, District of Columbia 20008
f Laboratory of Plasma Derivatives, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892
g Department of Biology, Georgetown University, Washington, District of Columbia 20057
| ABSTRACT |
|---|
|
|
|---|
embryo
| INTRODUCTION |
|---|
|
|
|---|
We previously determined that a major permeability barrier in the zebrafish embryo is the yolk syncytial layer (YSL) [24]. The permeability barrier of the yolk compartment and the YSL physiologically prevents both the entry of some cryoprotectants and the exit of water. As a result of these permeability restrictions, conventional approaches to zebrafish embryo cryopreservation result in the lethal destruction of the YSL [4]. Although this barrier can be circumvented by microinjecting cryoprotectant directly into the yolk [8], the need to remove water from the large yolk compartment remains. Because of the large size (approximately 800 µm) and low water permeability of the zebrafish embryo, the dehydration time of the yolk and blastoderm is significantly longer than the reported values for the mouse [9], cow [10], and permeabilized Drosophila embryos [11]. Therefore, to achieve successful cryopreservation of the fish embryo, membrane permeability must be enhanced to allow a more rapid efflux and influx of water and cryoprotectants. We predicted that permeability could be facilitated by introducing major intrinsic proteins (MIPs) into the membranes of zebrafish embryos.
The MIP proteins are distributed in a variety of biological membranes throughout the plant and animal kingdom [1219]. Generally, MIPs are transmembrane proteins that pass water, glycerol, and/or other small uncharged molecules. One important class of MIPs is the water channels, known as aquaporins (AQPs). AQPs, which are membrane-bound homotetrameric water channel proteins, have been identified in the plasma membranes of many fluid-transporting epithelia and endothelia [20, 21]. AQPs play a crucial role in a cell's ability to rapidly respond to changing osmotic conditions. When AQP mRNA is microinjected into frog oocytes, the aquaporin proteins are formed and inserted into the oocyte membrane, thereby greatly increasing the water permeability of the oocyte [12, 2224]. Insertion and expression of MIPs in embryos has not been accomplished, and could provide a solution to the impermeability of fish embryos.
Before attempting to modify zebrafish membrane permeability, we sought to understand selective membrane processes. The isosmotic point for zebrafish embryos is approximately 300 mOsm. Normally, vertebrate cells increase in volume (swell) under hypoosmotic conditions and decrease in volume (shrink) in hyperosmotic conditions. However, zebrafish embryos can develop normally in deionized water. The membrane mechanism responsible and the effects on the isosmotic value of zebrafish embryos are unknown. If the embryo isosmotic value were 40 mOsm (normal culture medium), they would differ from most vertebrate cells but would experience little damage in deionized water. However, if their cells had normal vertebrate osmolality (ca. 300 mOsm), they would be damaged by this treatment. One way to understand the isosmotic condition of an embryo is to test its volume behavior in nonpermeating solutions of various osmolalities.
Here, we report the results of experiments examining the permeability of natural and somatically altered zebrafish embryos. First, we investigated the osmotic properties of zebrafish embryos by measuring the volume changes of embryos under both hypo- and hyperosmotic conditions. Second, we determined whether AQPs exist in the native zebrafish embryo. Third, we introduced a fused mRNA of AQP3 and a reporter construct, green fluorescent protein (GFP), into early stage embryos and determined their effects on permeability in developing embryos. Previously, AQP3 mRNA inserted into frog oocytes increased several fold the permeability to both water and glycerol and to other cryoprotectants [25, 26] such as propylene glycol (PG). We then modeled the response of AQP3-expressing embryos to changes in membrane permeability to assess whether these modifications were sufficient to proceed with development of a suitable vitrification protocol.
The efficacy of vitrification is important because this type of cryopreservation circumvents the high chill sensitivity of fish embryos [5]. Vitrification relies upon a highly concentrated solution of cryoprotectants that both permeate and dehydrate the embryo. This process is followed by rapid cooling (i.e., hundreds of degrees per minute) of the embryo suspension. The high concentration of external and internal cryoprotectant forms a stable glassy state.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Zebrafish adults were maintained 1216 fish per 5-L tank (28.5°C, pH 7.0), illuminated with a 14L:10D cycle, and fed dry pellets (Tropical Micropellets, Hikare, Japan) twice each day. The developmental temperature was 28.5°C, and all developmental stages were described according to the method of Hagedorn et al. [3, 4]. All solutions throughout the study were prepared using an embryo culture medium, which was a 10% Hanks buffer as described by Westerfield [27]. Prior to experimentation, all embryos were dechorionated as previously described [3, 4]. Fish care met NIH animal care standards.
Osmotic Behavior of Zebrafish Embryos
We determined how water moved across the membrane in the native zebrafish embryo by measuring the volumetric water responses of embryos to a variety of hyper- and hypoosmotic solutions near to the fish's isosmotic point (Fig. 1). Embryos (100% epiboly, ca. 300 embryos/sample; n = 3) were packed into a tube, the interstitial water was removed, the cells were disrupted by freezing, and the contents were measured with a vapor pressure osmometer (Wescor, Logan, UT).
|
The temperature dependence of membrane transport, characterized by the activation energy (Ea) [15], can be used to distinguish between protein water channels and bilayer water transport. An Ea of <6 kcal/mol is indicative of AQP-mediated water transport, and an Ea of >10 kcal/mol is indicative of diffusion across the membrane bilayer [15]. We determined the Ea using an Arrhenius-type analysis and determined water permeability by measuring the volume change of embryos from 100% epiboly to three somites. Embryo volumes were held at constant temperature using a temperature controlled microscope stage (Linkam, Surrey, U.K.). The temperatures measured were 15°C, 22°C, and 29°C (n = 5 for each temperature), and measurements were made over 25 min with computer-aided videomicroscopy [3, 4] while the embryos were immersed in a nonpermeating hypertonic solution (0.35 M NaCl).
Construction and Translation of the AQP3-GFP Fused Protein
Using universal primers T7 and M13 forward, AQP3 cDNA was amplified by polymerase chain reaction (PCR) from pSPORT containing a rat AQP3 insert (generously donated by G. Frindt, GenBank accession NM031703). The product was purified with QIAQuick columns (Qiagen, Valencia, CA) and served as template in a subsequent PCR. A second PCR was used to add specific sequences to the 5' and 3' ends of AQP3 to permit ligation to GFP contained in a T3TS plasmid. The forward primer was 5'-GATC
CAC CATGGGTCGACAGAAGG-3' containing a BglII site (underlined), followed by the 4-base pair (bp) Kozak sequence and then 13 bp matching the 5' end of AQP3. The reverse primer was 5'-GATC
GATCTGCTCCTTGTGC-3', containing a PstI site (underlined) and 16 bp complementary to the 3' end of AQP3. While adding a cut site, the reverse primer also served to remove the stop codon of AQP3. GFP was amplified from T3TS plasmids containing fused AQP1-GFP. The forward primer was 5'-GATC
GTGAGCAAGGGCGAGG-3', containing a PstI site (underlined) and 16 bp matching the 5' end of GFP. The reverse primer was 5'-GATC
TTACTTGTACAGCTCGTCCATGC-3', containing a SpeI site (underlined) and 23 bp complementary to the 3' end of GFP. Purified AQP3 amplicons were digested with PstI and BglII, and purified GFP amplicons were digested with PstI and SpeI. After digestion, the 3' end of AQP3 was ligated to the 5' end of GFP.
This fused construct was ligated into the open reading frame of SpeI-and BglII-digested T3TS, transformed into ULTRA MAX DHFT-competent cells (Gibco BRL, Life Technologies, Gaithersburg, MD), and plated. Colonies were picked and replicated, and a portion was boiled to provide a crude extract template for a PCR with T3 and T7 universal primers. Resulting PCR products of approximately 2000 bp indicated AQP3-GFP inserts and were verified by sequencing purified PCR products using one-quarter scale BigDye Terminator Cycle Sequencing reactions (Applied Biosystems, Foster City, CA) on a Model 377 sequencer (PE Biosystems, Foster City, CA). Colonies containing complete AQP3-GFP constructs were grown overnight in 5-ml cultures, and plasmid DNA was isolated using QIAprep Spin mini preps (Qiagen). Plasmids were linearized with XbaI and transcribed with an m-CAP kit (m-Message Machine; Ambion, Austin, TX). The resulting capped RNA was cleaned with an RNeasy T3 promoter kit (Qiagen) and resuspended in 30 µl of RNase-free water. RNA was quantified by its optical density at 260 nm with a lambda spectrophotometer (PE Biosystems). All restriction endonucleases and the ligase were obtained from New England Biolabs (Beverly, MA).
Water and Cryoprotectant Permeability Measurements
We examined the change in permeability of PG in zebrafish embryos with and without expressed AQP3-GFP because PG is nontoxic and likely to be particularly useful for zebrafish cryopreservation [3, 6]. Embryos at the one- to eight-cell stage do not have a barrier between the yolk and the blastoderm, and therefore nucleic acids placed into the yolk are rapidly transported to the blastoderm cells [27, 28]. The yolks of these embryos were microinjected with 1.3 ng of AQP3-GFP mRNA (in a 2-nl volume of RNase-free water) or 2 nL of RNase-free water (controls) [22, 28, 29] and placed into sucrose medium (10% Hanks buffer supplemented with sucrose to 360 mOsm). After 2 h, GFP fluorescence was visible in both the yolk and blastoderm in >80% of the embryos (n > 3000). At this point, experimental embryos were sorted for GFP expression, and only GFP-positive embryos were used in further experiments.
Whole AQP3-GFP-treated and control embryos at 50% epiboly were immersed for 590 min in a 2 M 14C PG solution made up in a sucrose culture medium. After treatment, all embryos were rinsed twice in 2 M PG in sucrose culture medium for 12 min, and then the intact embryos were placed on blotting paper and immersed in 3 ml of scintillation cocktail (Packard UltimaGold; Packard Institute, Meridan, CT) and analyzed with a scintillation counter (Beckman-Coulter, Fullerton, CA). Disintegrations per minute were measured and converted to concentration of PG based on a dilution curve generated from known amounts of radiolabeled PG. To determine whether PG entered the yolk, we separated the blastoderm from the yolk with microscissors at 50% epiboly. Isolated blastodermal tissue forms a sphere that remains cohesive and stable in the sucrose medium for several hours. AQP3-GFP-treated and control blastodermal spheres were removed from the yolk, immersed in the 14C PG for 60 min, and treated as above.
The change in the water permeability (Lp) and cryoprotectant permeability (Ps) was analyzed using Micromath Scientist software (Micromath Corp., Salt Lake City, UT) using a one-compartment model [3, 4]. Lp and Ps were determined by numerically integrating the coupled transport equations and adjusting Lp and Ps until a best least-squares fit to the experimental data was obtained. For the control embryos, we used our previously determined value of Lp (0.004 µm min-1 atm-1) for native embryos [4] and obtained a Ps of 8.4 E-6 cm/min. AQP3-GFP-treated embryos yielded a Ps of 5.0 E-5 cm/min and an upper limit for Lp of 0.01 µm min-1 atm-1, because Lp is only poorly constrained by the data. Lp is generally lower in the presence of cryoprotectants, especially for zebrafish embryos [4]. Therefore, for modeling purposes, we employed a conservative estimate for Lp of 0.01 µm min-1 atm-1. To better define Lp, we measured shrinkage of AQP3-GFP-treated embryos in hyperosmotic medium (860 mOsm made up of 360 mOsm sucrose medium plus 0.25 M NaCl) over 10 min, yielding an Lp = 0.081 µm min-1 atm-1.
To estimate whether cryoprotectant moved into the yolk or merely bound to its surface, we immersed 50% epiboly embryos (AQP3-GFP-treated and controls) in 14C PG for 90 min. Embryos were rinsed four times in 2 M PG/sucrose medium and then placed into a fifth 2 M PG/sucrose medium supplemented with 0.25 M NaCl. The yolks were cut with microscissors, the blastoderm and residual membranes were removed, and a yolk sample from each embryo (unknown amount) was removed with a pipette and placed onto a filter and analyzed with a scintillation counter, as above. We conducted the experiment twice but did not average the results because the amount of yolk sampled per embryo was unquantifiable.
Statistical Analysis
All statistical analyses were conducted using StatView 4.5 (SAS Institute, Cary, NC) for the Macintosh. We used nonparametric tests for all comparisons because of small sample size and unknown underlying distributions. Kruskal-Wallis tests were employed when two or more groups were being compared. To compare uptake of PG over time for experimental groups and controls, we used simple regression statistics and then computed F values to compare the slopes of two regressions.
| RESULTS |
|---|
|
|
|---|
300 mOsm were unchanged in volume, whereas those in solutions of >300 mOsm decreased in volume (Fig. 1). Specifically, embryos immersed in hypoosmotic solutions (0 mOsm and 325 mOsm) showed the same volume as did control embryos (40 mOsm) (Kruskal-Wallis H2 = 0.95, not significant). However, those embryos in the hyperosmotic solutions (670 mOsm and 1350 mOsm) and control embryos (40 mOsm) were significantly different in volume (Kruskal-Wallis H2 = 15.19, P < 0.05) (Fig. 1). Thus, an asymmetry or rectification exists in zebrafish embryo membranes that allows water to leave readily but not to reenter. Although zebrafish have a complex membrane mechanism controlling water movement, we verified that the embryos do not have AQPs. We examined the way water moves across the fish membranes at various temperatures and measured an Ea of 22 kcal/mol in zebrafish embryos. This indicated passive membrane diffusion rather than AQP-mediated transport.
We successfully introduced mammalian AQP3 into the zebrafish embryo. The AQP3 cDNA was fused to the GFP cDNA. GFP provided a phenotypic marker rapidly identifying embryos expressing the fusion product (AQP3-GFP). During development the AQP-GFP begins to be expressed within a few hours, as is evident by the strong green fluorescence in the blastoderm (Fig. 2, a and b). The blastoderm cells continue to divide, producing the YSL. At 100% epiboly, the RNA is still active, producing a bright fluorescent glow throughout the embryo (Fig. 2c). This glow suggests that the pores are uniformly distributed throughout the embryo at this stage. As the embryo develops for another 12 h, this pattern of growth and distribution of the water channels is maintained (Fig. 2d). Based on anatomical, developmental, and physiological criteria discussed previously [3, 4], we produced normal larvae that expressed AQP3-GFP in somatic tissue throughout the embryo for up to 4 days. The long-term effect of these modifications on survival and reproduction is of crucial importance for the success of cryopreservation, and studies examining the full developmental effects are underway.
|
In exposing embryos to radiolabeled PG, our experiments demonstrated that AQP3-GFP-expressing embryos experienced higher rates of PG uptake than do control embryos (Fig. 3). Linear regression models revealed significant effects of time on amount of PG uptake into the embryos for both controls (F(1,13) = 23.23, P = 0.0003, R2 = 0.61, Y = 2.30 + 0.28X) and experimental embryos (F(1,10) = 88.77, P = 0.0001, R2 = 0.89, Y = -1.79 + 1.37X). However, the slopes of the two lines are significantly different (F(1,23) = 9.36, P < 0.01), revealing the higher rate of uptake in AQP3-GFP-expressing embryos. To understand how Lp and Ps changed in the AQP3-GFP-treated embryos, 14C PG uptake data were fit using our permeability model. These data suggest that the Lp and Ps of AQP3-GFP-treated embryos are approximately 6 times and 2.5 times greater than those values for the controls, respectively.
|
To cryopreserve embryos, the cryoprotectant must permeate both the blastoderm and the yolk. The AQP3-GFP-expressing spheres, control spheres, and control intact embryos displayed similar levels of 14C PG uptake (Fig. 3). Although the blastoderm was expressing AQP3-GFP, its permeability to PG was virtually equal to the natural permeability of the control blastoderm. Therefore, the additional 14C PG observed in the intact AQP3-GFP-treated embryos should represent the amount transported into the yolk. We further verified this result by directly measuring the amount of 14C PG entering yolk samples (Fig. 4).
|
The changes that we observed in cryoprotectant and water permeability of the AQP3-GFP-treated embryos are modest. However, after modeling the embryo response, even modest changes in permeability produced great changes over time. After 135 min, the PG concentration determined in our model for AQP3-GFP-treated embryos was 5.4 M, well within the range found necessary for vitrification of cells (Fig. 5). These predictive models will aid in designing future toxicity and vitrification trials.
|
| DISCUSSION |
|---|
|
|
|---|
Regardless of their current or historic role, the presence of rectifying membranes combined with the YSL (restricting both water and cryoprotectant transport) may explain the difficulty encountered when trying to cryopreserve fish embryos with conventional methods. By modifying the membranes with AQP3-GFP, we were able to change the permeability of the membrane to both water and cryoprotectants. Although these changes are modest, we believe they are sufficient for cryopreservation. Our results indicate that radiolabeled PG diffused into the yolk. Our previous studies [24] indicated that the YSL blocked cryoprotectant entry into the yolk. Thus, our results suggest that AQP3-GFP channels within the YSL now permit the movement of cryoprotectants into the yolk. This finding is crucial because one of the main barriers to fish embryo cryopreservation is that little or no cyroprotectant can cross the YSL, and cryodamage results [24]. Clearly, this barrier has been overcome with these methods.
Although water channels have been described and studied in frog oocytes [15, 22], the use of these channels in embryos and the application of these techniques to cryopreservation have not been previously described and will have a profound effect on genome resource banking. Using mRNA to modify the fish's membranes produces transient expression in somatic cells that will have no impact on the germline. These types of somatic changes are ideal for genomic resource banking because only the stored embryos in the bank will bear these modifications.
The cryopreservation of teleost embryos will greatly affect the conservation of rare or threatened species, medical research, and aquaculture. For conservation, the development of frozen embryo technology would permit the creation of ex situ populations to preserve genetic diversity and assist in the prevention of extinctions in natural populations [3638]. The zebrafish has become a widely used vertebrate model in medical research for developmental and genetic studies. Genetically characterized strains of zebrafish are being used to understand gene function, with applications to human disease. These genetic lines are maintained in live culture and thus are susceptible to loss or modification and are expensive to maintain. Fish is also an essential protein source for much of the world's population. Many fish species used in aquaculture spawn only once each year. The ability to routinely cryopreserve fish embryos would contribute to more efficient, cost-effective, and year-round fish production. This technology could aid in the ex situ conservation of the almost 46 000 species of fish, birds, amphibians, and reptiles that have yet to be cryopreserved.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
1 This work was supported by grants to D.F. and R.F. from Friends of the National Zoo, to B.P. from the National Institutes of Health (K01 RR00135), and to M.H. from the National Institutes of Health (R01 RR08769), by the Maryland Sea Grant College, and by a private donation from Mrs. S. Sichel. ![]()
2 Correspondence: M. Hagedorn, Department of Reproductive Sciences, National Zoological Park, Smithsonian Institution, 3001 Connecticut Ave., NW, Washington, DC 20008. FAX: 202-673-4377; hagedornm{at}nzp.si.edu ![]()
3 These authors contributed equally to this work ![]()
Accepted: April 17, 2002.
Received: December 20, 2001.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. N. Philip, S.-X. Yi, M. A. Elnitsky, and R. E. Lee Jr Aquaporins play a role in desiccation and freeze tolerance in larvae of the goldenrod gall fly, Eurosta solidaginis J. Exp. Biol., April 1, 2008; 211(7): 1114 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tanghe, P. Van Dijck, D. Colavizza, and J. M. Thevelein Aquaporin-Mediated Improvement of Freeze Tolerance of Saccharomyces cerevisiae Is Restricted to Rapid Freezing Conditions Appl. Envir. Microbiol., June 1, 2004; 70(6): 3377 - 3382. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |